{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:31:06Z","timestamp":1793521866159,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ajog.2023.07.022","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T12:00:43Z","timestamp":1689681643000},"page":"109-117.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["The effect of valacyclovir on secondary prevention\u00a0of congenital cytomegalovirus infection,\u00a0following primary maternal infection acquired periconceptionally or in the first trimester of\u00a0pregnancy. An individual patient data meta-analysis"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-6887","authenticated-orcid":false,"given":"Christos","family":"Chatzakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Shahar-Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Faure-Bardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Picone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Hadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Egloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vivanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Sotiriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leruez-Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.07.022_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/infdis\/168.3.552","article-title":"Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990","volume":"168","author":"Fowler","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2023.07.022_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ajog.2023.07.022_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2458-5-70","article-title":"Washing our hands of the congenital cytomegalovirus disease epidemic","volume":"5","author":"Cannon","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ajog.2023.07.022_bib4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1542\/peds.107.5.1227","article-title":"Secondary maternal cytomegalovirus infection--a significant cause of congenital disease","volume":"107","author":"Ahlfors","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2023.07.022_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/peds.104.1.55","article-title":"Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus","volume":"104","author":"Boppana","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2023.07.022_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.07.022_bib8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/uog.23685","article-title":"Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy","volume":"58","author":"Faure-Bardon","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/uog.26039","article-title":"New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus","volume":"61","author":"Egloff","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/uog.23724","article-title":"Acute kidney injury after valacyclovir administration for prevention of congenital cytomegalovirus infection","volume":"58","author":"Schurder","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A review: Mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.ajog.2023.07.022_bib12","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.07.022_bib13","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"Robins-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.07.022_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jrsm.1303","article-title":"A\u00a0comparison of one-stage vs two-stage individual patient data meta-analysis methods: a simulation study","volume":"9","author":"Kontopantelis","year":"2018","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ajog.2023.07.022_bib15","series-title":"Individual participant data meta-analysis: a handbook for healthcare research","year":"2021"},{"key":"10.1016\/j.ajog.2023.07.022_bib16","series-title":"Flexible imputation of missing data","author":"van Buuren","year":"2018"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.07.022_bib17","first-page":"16","article-title":"OC05.08: Valacyclovir is effective to prevent vertical transmission after maternal primary infection with CMV in the first trimester of pregnancy","volume":"60","author":"Faure-Bardon","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/pharmaceutics15010163","article-title":"Optimizing antiviral dosing for HSV and CMV treatment in immunocompromised patients","volume":"15","author":"Huntjens","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajog.2023.07.022_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A\u00a0review: mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.ajog.2023.07.022_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","article-title":"Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis","volume":"61","author":"D\u2019Antonio","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/uog.22060","article-title":"The use and abuse of meta-analysis","volume":"55","author":"Sotiriadis","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib22","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3389\/fphar.2019.00874","article-title":"Risk evaluation for acute kidney injury induced by the concomitant use of valacyclovir, analgesics, and renin-angiotensin system inhibitors: the detection of signals of drug-drug interactions","volume":"10","author":"Inaba","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajog.2023.07.022_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/uog.26128","article-title":"Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: systematic review and meta-analysis","volume":"61","author":"Chatzakis","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib24","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1080\/14767058.2020.1843016","article-title":"Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection","volume":"35","author":"Gonc\u00e9","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.07.022_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/uog.24753","article-title":"Renal toxicity of high-dosage valacyclovir for secondary prevention of congenital cytomegalovirus infection: a dose regimen-related issue","volume":"58","author":"Ville","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib26","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.jcv.2020.104351","article-title":"Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: a case-series","volume":"127","author":"De Santis","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ajog.2023.07.022_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jogoh.2019.01.003","article-title":"Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection","volume":"48","author":"Codaccioni","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ajog.2023.07.022_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jinf.2019.08.015","article-title":"Prenatal valacyclovir treatment of fetal citomegalovirus infection: a case series","volume":"79","author":"De Santis","year":"2019","journal-title":"J Infect"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2023.07.022_bib29","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0163-4453(17)30197-4","article-title":"Congenital cytomegalovirus - who, when, what-with and why to treat?","volume":"74","author":"Lim","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.ajog.2023.07.022_bib30","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.022_bib31","doi-asserted-by":"crossref","unstructured":"Roxby AC, Atkinson C, Asbj\u00f6rnsd\u00f3ttir K, et al. Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women. PLoS One. 2014;9:e87855.","DOI":"10.1371\/journal.pone.0087855"},{"key":"10.1016\/j.ajog.2023.07.022_bib32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-0528.2007.01308.x","article-title":"Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection","volume":"114","author":"Jacquemard","year":"2007","journal-title":"BJOG"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823004702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823004702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:43:49Z","timestamp":1757591029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823004702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0002937823004702"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.07.022","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of valacyclovir on secondary prevention\u00a0of congenital cytomegalovirus infection,\u00a0following primary maternal infection acquired periconceptionally or in the first trimester of\u00a0pregnancy. An individual patient data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}